Drug Approval | March 02, 2022
USFDA approves first generic version of Apokyn cartridges
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
Divalproex Sodium Extended-Release tablets are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, as monotherapy and adjunctive therapy and prophylaxis of migraine headaches
This policy will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at medical institutes across the country
Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
It has a total of 50 ANDA approvals from USFDA
The tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency
Clarithromycin tablets USP, 250 mg and 500 mg have an estimated market size of US $ 11 million for twelve months ending September 2021 according to IQVIA
Potassium chloride is used to prevent or to treat low blood levels of potassium
Subscribe To Our Newsletter & Stay Updated
